Successful self-regulation in the gaming industry could be a model for trading apps in managing corporate reputation and protecting their license to operate.

As pharma companies look to their next drug development and launch, a shift in approach could mitigate their reputation risk, writes Crystal Benton.

As COVID-19 shifts from a health to economic crisis, these are the top economic concerns that leaders in corporate America should act on now.

The expertise of American businesses and a political campaign mentality can carry us from vaccine development to herd-immunity vaccination coverage.

Public intent to receive a COVID-19 vaccine is more nuanced than most polling captures and more optimistic for public health than is being widely reported.

Purple partner Chris Durlak is a featured expert in the latest issue of The CEO Forum magazine, sharing insights for CEOs from Purple Futurecasting.

As the COVID crisis has worsened across the U.S. since summer, partisan attitudes have shifted on whether it's more of a health or economic crisis.

Political alliances are shifting, and headwinds and tailwinds are becoming harder to read. What we see, what it means, and what you should do about it.

Where a person gets their news and their political party identification drive unique factors of COVID-19 vaccine hesitancy.

What challenges and opportunities lie ahead for corporate reputation? Get in-depth perspectives from leaders who are building and protecting their company’s reputation, every day.